Silicon Valley Capital Partners

Position in LLY — ELI LILLY & Co

CIK 1673633 SAN JOSE, CA

Position in LLY

as of Mar 31, 2026 · filed May 19, 2026 Compact

Position Value

$11,965,287

-$7,069,446 QoQ

Shares Held

13,009

-26.6% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

1.58%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Silicon Valley Capital Partners holds $14,966,250 across 12 Drug Manufacturers - General names. LLY ranks #1 (79.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	13,009	$11,965,287
2	JNJ	Johnson & Johnson	9,659	$2,361,045
3	PFE	Pfizer Inc	7,397	$207,707
4	AMGN	Amgen Inc	487	$171,350
5	ABBV	AbbVie Inc.	580	$126,144
6	BMY	Bristol Myers Squibb Co	1,154	$69,990
7	MRK	Merck & Co., Inc.	380	$45,710
8	NVO	Novo Nordisk A S	276	$10,143

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$11,965,287	13,009	-26.6%	Shares	Sole	2026-05-19
2025-12-31	$19,034,733	17,712	-9.7%	Shares	Sole	2026-02-13
2025-09-30	$14,970,060	19,620	+8.3%	Shares	Sole	2025-11-17
2025-06-30	$14,125,863	18,121	+12.3%	Shares	Sole	2025-09-11
2025-03-31	$13,322,754	16,131	+33.4%	Shares	Sole	2025-05-28
2024-12-31	$9,334,252	12,091	+4959.0%	Shares	Sole	2025-01-29
2024-09-30	$211,739	239	0.0%	Shares	Sole	2024-10-30
2024-06-30	$216,385	239	+71.9%	Shares	Sole	2024-10-30
2024-03-31	$108,136	139	0.0%	Shares	Sole	2024-04-29
2023-12-31	$81,025	139	+0.7%	Shares	Sole	2024-02-14
2023-09-30	$74,123	138	0.0%	Shares	Sole	2023-11-06
2023-06-30	$64,719	138	+91.7%	Shares	Sole	2023-08-14
2023-03-31	$24,726	72	—	Shares	Sole	2023-05-10
No filing history on record for this holder in this stock.